- Report
- November 2024
- 186 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- August 2024
- 142 Pages
Global
From €2843EUR$2,999USD£2,375GBP
- Report
- February 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- February 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- February 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- February 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- March 2021
- 216 Pages
Global
From €1303EUR$1,375USD£1,089GBP
€2606EUR$2,750USD£2,178GBP
- Report
- June 2023
- 186 Pages
Global
From €4407EUR$4,650USD£3,682GBP
- Report
- October 2024
- 93 Pages
Global
From €3500EUR$3,956USD£3,026GBP
- Report
- July 2023
- 95 Pages
Global
From €3500EUR$3,956USD£3,026GBP
- Report
- November 2021
- 1032 Pages
Global
From €4739EUR$5,000USD£3,959GBP
Metabolomics biomarkers are a type of biomarker used to measure and analyze the metabolites present in a biological sample. Metabolites are small molecules that are produced as a result of metabolic processes, and they can provide valuable information about the health of an individual. Metabolomics biomarkers are used to identify and quantify metabolites in order to gain insight into the metabolic pathways of an organism. This information can be used to diagnose diseases, monitor the progression of a disease, and evaluate the effectiveness of treatments.
Metabolomics biomarkers are used in a variety of fields, including drug discovery, toxicology, nutrition, and personalized medicine. They are also used to identify biomarkers for diseases such as cancer, diabetes, and cardiovascular disease.
Companies in the metabolomics biomarker market include Metabolon, Biocrates Life Sciences, Metabolomic Technologies, Metabolon, and Metabolomics Technologies. Show Less Read more